Insiders · Profile

Monia Brett P

Chief Executive Officer at IONIS PHARMACEUTICALS. Filing since 3 Jul 2012. CIK 0001537529

Company
Date
Role
Action
Shares
Amount
Of holding
26 Jun 2026
Chief Executive Officer
Sold on a plan
50,000
$4.03M
16.9%
25 Jun 2026
Chief Executive Officer
Sold on a plan
21,072
$1.65M
7.9%
24 Jun 2026
Chief Executive Officer
Sold on a plan
14,565
$1.14M
5.6%
14 May 2026
Chief Executive Officer
Sold on a plan
3,220
$253.35K
1.3%
13 May 2026
Chief Executive Officer
Sold on a plan
1,316
$102.67K
0.5%
10 Mar 2026
Chief Executive Officer
Sold on a plan
34,103
$2.59M
12.3%
9 Mar 2026
Chief Executive Officer
Sold on a plan
126,670
$9.53M
34.3%
6 Feb 2026
Chief Executive Officer
Sold on a plan
29,430
$2.52M
10.4%
30 Jan 2026
Chief Executive Officer
Sold at will
62,970
$5.21M
18.2%
16 Jan 2026
Chief Executive Officer
Sold at will
44,034
$3.29M
16.4%
6 Oct 2025
Chief Executive Officer
Sold on a plan
437
$30.27K
0.2%
3 Sep 2025
Chief Executive Officer
Sold at will
203,814
$12.29M
53.1%
30 Jul 2025
Chief Executive Officer
Sold on a plan
2,432
$109.44K
1.3%
11 Jul 2025
Chief Executive Officer
Sold on a plan
1,160
$48.42K
0.6%
11 Mar 2025
Chief Executive Officer
Sold on a plan
140
$4.52K
0.1%
4 Feb 2025
Chief Executive Officer
Sold on a plan
38,843
$1.23M
17.7%
31 Jan 2025
Chief Executive Officer
Sold at will
13,242
$429.66K
5.7%
16 Jan 2025
Chief Executive Officer
Sold at will
33,445
$1.09M
13.9%
12 Nov 2024
Chief Executive Officer
Sold on a plan
6,630
$252.29K
3.8%
16 Feb 2024
Chief Executive Officer
Sold on a plan
387
$17.22K
0.2%
2 Feb 2024
Chief Executive Officer
Sold at will
23,501
$1.16M
11.9%
25 Jan 2024
Chief Executive Officer
Sold on a plan
2,285
$118.25K
1.5%
17 Jan 2024
Chief Executive Officer
Sold at will
32,059
$1.62M
17.2%
21 Dec 2023
Chief Executive Officer
Sold on a plan
17,500
$862.58K
12.9%
20 Dec 2023
Chief Executive Officer
Sold on a plan
6,500
$322.64K
5.2%
14 Dec 2023
Chief Executive Officer
Sold on a plan
24,000
$1.19M
16.9%
12 Oct 2023
Chief Executive Officer
Sold on a plan
3,770
$173.42K
3.1%
7 Jul 2023
Chief Executive Officer
Sold on a plan
18,650
$787.95K
13.3%
22 May 2023
Chief Executive Officer
Sold on a plan
4,931
$197.91K
3.4%
6 Feb 2023
Chief Executive Officer
Sold, plan not stated
24,651
$1.00M
14.5%
18 Jan 2023
Chief Executive Officer
Sold, plan not stated
25,066
$989.95K
17.2%
1 Apr 2022
Chief Executive Officer
Sold, plan not stated
355
$13.31K
0.4%
1 Mar 2021
Chief Executive Officer
Sold, plan not stated
236
$12.81K
0.5%
4 Dec 2020
Chief Executive Officer
Sold, plan not stated
23,840
$1.22M
45.2%
2 Dec 2020
Chief Executive Officer
Sold, plan not stated
21,160
$1.09M
42.3%
1 Sep 2020
Chief Executive Officer
Sold, plan not stated
314
$16.86K
1.1%
2 Jan 2020
Chief Executive Officer
Sold, plan not stated
173
$10.42K
1.1%
20 Nov 2019
COO & SVP, Translational Med
Sold, plan not stated
5,776
$346.62K
26.0%
2 Jul 2019
Chief Operating Officer
Sold, plan not stated
210
$13.94K
0.9%
2 Jan 2019
Chief Operating Officer
Sold, plan not stated
214
$11.45K
1.3%
23 Nov 2018
Chief Operating Officer
Sold, plan not stated
34,000
$1.87M
68.2%
27 Aug 2018
Chief Operating Officer
Sold, plan not stated
16,493
$890.62K
51.0%
24 Jul 2018
Chief Operating Officer
Sold, plan not stated
156
$7.34K
1.0%
16 Jan 2018
COO
Sold, plan not stated
2,821
$146.01K
15.2%
2 Jan 2018
SVP, Antisense Drug Discovery
Sold, plan not stated
163
$8.15K
1.4%
3 Jul 2017
SVP, Antisense Drug Discovery
Sold, plan not stated
309
$15.87K
2.6%
17 Jan 2017
SVP, Antisense Drug Discovery
Sold, plan not stated
2,502
$115.82K
22.3%
3 Jan 2017
SVP, Antisense Drug Discovery
Sold, plan not stated
309
$15.02K
3.8%
20 Dec 2016
SVP, Antisense Drug Discovery
Sold, plan not stated
130
$6.82K
1.6%
19 Jan 2016
SVP, Antisense Drug Discovery
Sold, plan not stated
2,208
$91.54K
32.1%
4 Jan 2016
SVP, Antisense Drug Discovery
Sold, plan not stated
127
$7.75K
2.8%
2 Jul 2015
SVP, Antisense Drug Discovery
Sold, plan not stated
198
$11.15K
4.3%
8 Jun 2015
SVP, Antisense Drug Discovery
Sold, plan not stated
7,600
$503.28K
63.2%
16 Jan 2015
SVP, Antisense Drug Discovery
Sold, plan not stated
1,534
$104.26K
40.4%
2 Jan 2015
SVP, Antisense Drug Discovery
Sold, plan not stated
76
$4.77K
3.8%
26 Aug 2014
SVP, Antisense Drug Discovery
Sold, plan not stated
27,344
$1.04M
93.8%
31 Jul 2014
SVP, Antisense Drug Discovery
Sold, plan not stated
79
$2.49K
4.2%
16 Jan 2014
SVP, Antisense Drug Discovery
Sold, plan not stated
821
$38.65K
37.6%
2 Jan 2014
SVP, Antisense Drug Discovery
Sold, plan not stated
362
$14.21K
42.7%
20 Sep 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
18,281
$656.11K
96.0%
19 Sep 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
50,000
$1.68M
98.5%
26 Aug 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
2,909
$74.40K
79.1%
2 Jul 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
215
$6.17K
3.5%
11 Jun 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
9,375
$222.75K
62.2%
22 Apr 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
17,000
$361.42K
74.9%
19 Apr 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
2,500
$53.13K
30.5%
5 Mar 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
18,240
$307.60K
76.2%
16 Jan 2013
SVP, Antisense Drug Discovery
Sold, plan not stated
330
$4.62K
5.6%
3 Jan 2013
VP, Antisense Drug Discovery
Sold, plan not stated
311
$3.37K
5.6%
6 Sep 2012
VP, Antisense Drug Discovery
Sold, plan not stated
12,031
$183.47K
69.1%
3 Jul 2012
SVP, Antisense Drug Discovery
Sold, plan not stated
587
$7.58K
9.8%
71 decisions on file.